A case of a newly developed yellow neointima at stent implanted site 1 year after sirolimus-eluting stent placement Angioscopic findings

被引:10
作者
Kawakami, Hideo [1 ]
Matsuoka, Hiroshi [1 ]
Oshita, Akira [1 ]
Kono, Tamami [1 ]
Shigemi, Susumu [1 ]
机构
[1] Ehime Prefectural Imabari Hosp, Dept Cardiol, Imabari, Ehime 7940006, Japan
关键词
Sirolimus-eluting stent; Angioscopy; Neointimal formation; Inflammation; INTRAVASCULAR ULTRASOUND; CORONARY-ARTERY; HYPERSENSITIVITY; PROLIFERATION; PLAQUE;
D O I
10.1016/j.jjcc.2008.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary angioscopy is a useful tool, for understanding plaque characteristics through the plaque color and surface thrombus formation. We experienced an interesting case of a newly developed yellow neointima 400 days after a sirolimus-eluting stent implantation. A 72-year-old woman suffering from angina pectoris was admitted to our hospital. Coronary angiography revealed severe stenosis at the proximal left descending artery and she was implanted with a sirolimus-eluting stent. Coronary angioscopic observation immediately after stent implantation revealed the presence of yellow plaque only at the most severe stenosis lesion in the stent placement site. We performed a coronary angiography 400 days after the sirolimus-eluting stent implantation and did not find an in-stent restenosis. An intravascular ultrasound indicated minimum neointimal formation. By coronary angioscopy, we could clearly observe that the neointima had covered the surface of the stent struts; the stent struts were barely visible under the neointima. Surprisingly, neointima formed in response to the sirolimus-eluting stent was entirety yellow. Precise mechanisms of producing yellow neointima was unknown, we may observe a pathologic neointima induced by sirolimus-eluting stent. (C) 2008 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 15 条
  • [1] Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients
    Aoki, J
    Abizaid, AC
    Serruys, PW
    Ong, ATL
    Boersma, E
    Sousa, JE
    Bruining, N
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (09) : 1670 - 1676
  • [2] Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation - Long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up
    Degertekin, M
    Serruys, PW
    Foley, DP
    Tanabe, K
    Regar, E
    Vos, J
    Smits, PC
    van der Giessen, WJ
    van den Brand, M
    de Feyter, P
    Popma, JJ
    [J]. CIRCULATION, 2002, 106 (13) : 1610 - 1613
  • [3] Vascular responses to drug eluting stents - Importance of delayed healing
    Finn, Aloke V.
    Nakazawa, Gaku
    Joner, Michael
    Kolodgie, Frank D.
    Mont, Erik K.
    Gold, Herman K.
    Virmani, Renu
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) : 1500 - 1510
  • [4] Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone
    Fujimoto, Hajime
    Tao, Susumu
    Dohi, Tomotaka
    Ito, Sachiko
    Masuda, Jun
    Haruo, Mitani
    Fujimoto, Yo
    Maehara, Akiko
    Yamaguchi, Tetsu
    Ishiwata, Sugao
    Ohno, Minoru
    [J]. JOURNAL OF CARDIOLOGY, 2008, 51 (01) : 18 - 24
  • [5] Medial necrosis due to sirolimus-eluting stent implantation in human coronary artery
    Inoue, Katsumi
    Mitsudo, Kazuaki
    Nobuyoshi, Masakiyo
    [J]. JOURNAL OF CARDIOLOGY, 2008, 51 (01) : 60 - 64
  • [6] Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
    Joner, Michael
    Finn, Aloke V.
    Farb, Andrew
    Mont, Erik K.
    Kolodgie, Frank D.
    Ladich, Elena
    Kutys, Robert
    Skorija, Kristi
    Gold, Herman K.
    Virmani, Renu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) : 193 - 202
  • [7] A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
    Morice, M
    Serruys, PW
    Sousa, JE
    Fajadet, J
    Hayashi, EB
    Perin, M
    Colombo, A
    Schuler, G
    Barragan, P
    Guagliumi, G
    Molnar, F
    Falotico, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) : 1773 - 1780
  • [8] Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    Moses, JW
    Leon, MB
    Popma, JJ
    Fitzgerald, PJ
    Holmes, DR
    O'Shaughnessy, C
    Caputo, RP
    Kereiakes, DJ
    Williams, DO
    Teirstein, PS
    Jaeger, JL
    Kuntz, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) : 1315 - 1323
  • [9] Hypersensitivity cases associated with drug-eluting coronary stents - A review of available cases from the research on adverse drug events and reports (RADAR) project
    Nebeker, JR
    Virmani, R
    Bennett, CL
    Hoffman, JM
    Samore, MH
    Alvarez, J
    Davidson, CJ
    McKoy, JM
    Raisch, DW
    Whisenant, BK
    Yarnold, PR
    Belknap, SM
    West, DP
    Gage, JE
    Morse, RE
    Gligoric, G
    Davidson, L
    Feldman, MD
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 175 - 181
  • [10] Morphologic changes in infarct-related plaque after coronary stent placement - A serial angioscopy study
    Sakai, S
    Mizuno, K
    Yokoyama, S
    Tanabe, J
    Shinada, T
    Seimiya, K
    Takano, M
    Ohba, T
    Tomimura, M
    Uemura, R
    Imaizumi, T
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (09) : 1558 - 1565